VisVires New Protein
VisVires New Protein (VVNP) is a venture capital fund that aims to achieve outsize returns from focused investments on disruptive technologies for the food and feed system.
Today’s life sciences and new technologies deliver opportunities to redesign the food supply system from the ground up.
We focus our investments on companies which bring pioneering solutions to key food-related issues, along the whole supply chain. Biotechnology, data sciences, as well as automation and novel processes, will be crucial to sustainable animal feed, green aquaculture and innovative human food product development.
Food and feed, the next frontier
VVNP was created on the premises that the foreseeable shortage in animal protein would spur the development of innovative solutions and generate opportunities to invest. But the stakes are even higher. Today, in an arguably more complex food ecosystem, we see many factors driving the need to comprehensively rethink the whole food production and supply chain: globalization of agriculture and animal farming, changes in dietary habits in developing countries, impact of climate change, the multiple causes and issues of food waste, as well as consumer demand for healthier food propositions.
The commitment to innovation
We are strongly committed to innovation. Old models of food production will have to be replaced by new solutions. A more scientific approach will be crucial to provide solutions for the long term. Tomorrow our resources will diminish while our technological skills will increase. Some technological advancements are particularly timely to address the above challenges. They can give life to disruptive models and provide transformational services. This offers a whole breadth of opportunities to investors.
Bringing in innovation and capital, VVNP is building a portfolio of outstanding companies with creative, scientifically rigorous and delivery-focused management teams.
We invest in companies at early stages of their development, from angel all the way to series B.
OUR INVESTMENT SCOPE
Addressing the foreseeable shortage of
Our agricultural model has not yet evolved to face the challenges brought by a growing population with changing diets.
Innovation will help make animal farming more sustainable, and novel processes will develop scalable new sources of protein.
Leveraging an increased understanding of
food and health interaction
Over the past few decades, food has contributed to exacerbate a number of metabolic and chronic diseases.
The start ups we are looking at are working on making food a solution, not a problem.
Building a safer food chain
whilst reducing waste
More than a third of the food produced is wasted along the food chain in both developed and developing countries.
Improving food safety practices, producing closer to the consumer, reusing waste, creating sustainable packaging are many ways to reduce spoilage.
Who we are
Matthieu Vermersch .
Matthieu has over 25 years of experience in investment management with a concentration on Asian regions. Matthieu’s investment experience has been centred primarily on thematic investing where he has successfully identified specific themes and designed strategies to profit from them. In mid-2012, Matthieu started to explore the imbalance created by China in the world market of animal protein. He quickly became convinced that it was the tipping point of a multi-decade investment opportunity. In late 2013-early 2014, Matthieu decided to concentrate solely on this and founded New Protein Capital (NPC). The scope of investment of NPC has since been expanded to include the multiple challenges of the food and feed production processes.
Prior to founding NPC in 2014, Matthieu was with Everest Capital, a large independent investment firm with offices in the US and in Singapore, for over 16 years. At Everest Capital, he was a Senior Managing Director and the Director of Research as well as a member of the Executive and Investment committees.
Prior to Everest, Matthieu was with Banque Paribas, in Hong Kong, New York, Taipei and Paris.
Matthieu has a postgraduate degree in Corporate Finance from Universite Paris Dauphine and has a graduate degree from Institut d'Etudes Politiques de Paris (Sciences Po).
Marie-Anne has acquired a diverse professional background managing non-profit as well as for profit projects in Africa, Indonesia and Singapore with a strong emphasis on environmentally friendly ventures. She has spent most of her professional life between Asia and the USA. Marie-Anne has an extensive knowledge of the major issues facing food and feed industries today. She is driving our research efforts and makes sure our investment scope stays within the sustainable and scalable boundaries. Marie-Anne is passionate about finding solutions for these pressing global problems.
She has a double major in Law and Chinese Language and Civilization.
Gerard heads the fund's business development efforts and supports the investment team. From 2012 to 2016, he was an Analyst and Head of Special Projects at Aquilus Pte Ltd, a research and investment office for a European hedge fund. Prior to that, he worked as an Investment Analyst at Saratoga Capital, an Indonesia-focused private equity firm. Gerard has a graduate degree in Banking and Finance from University of London International Programme (LSE).
Candice is part of the portfolio management team of VVNP.
Prior to this, she was an investment manager with Singapore Technologies Telemedia. She previously was the deputy head of the Product Management team of Partners Group, before serving as an assistant vice president with Keppel.
Candice has a B.Sc (Life Sciences) from the National University of Singapore, a Master in Finance from the University of Wales, and is currently pursuing her Doctorate with Manchester Business School
Martin is part of the deal-sourcing team at VVNP.
Previously, he was a researcher at the distinguished Lawrence Berkeley National Laboratory in California. Prior, Martin spent close to a year in Algae and Aquaculture research in Europe.
Martin is a master student with France’s top life sciences school, AgroParisTech
Tom helps manage our pipeline at VVNP.
Prior to this, he worked at Suez where he led studies on waste recycling and valorisation. Tom also gained first hand experience living and working on agricultural farms in Europe.
Tom is a master student with France’s top life sciences school, AgroParisTech.
* As of 1st Sept. 2016, New Protein Capital operates as a division of VisVires Capital whose team biographies can be found here.
Our firm is strategically based in Singapore, Southeast Asia's research and development hub, which also offers easy access to the greater Asia region. From here we can identify new markets and monitor important new developments in traditional agriculture and aquaculture industries. Singapore is also home to a myriad of scientific research centres and large food-related businesses.
With its receptiveness to new technologies and focus on research, the city is an attractive location for research talents and is a great place for ground-breaking innovation.
We are an early investor in YNSECT, a startup that produces insect meal, an environmentally sustainable alternative to fishmeal. This is ground-breaking as the price of fishmeal has already tripled in the last 10 years. YNSECT also produces extensive green chemistry products. We applaud its effective use of robotics and advanced engineering to potentially rear insects at an unprecedented large scale.
YNSECT was created in 2011 by four partners (Antoine Hubert, Jean-Gabriel Levon, Fabrice Berro and Alexis Angot). In 2014, the company has developed an insect biorefinery pilot at Genopole in Evry.
VisVires New Protein is the lead investor in Dublin-based startup Nuritas. The company was founded by Dr. Nora Khaldi, a mathematician with a PhD in Molecular Evolution and Bioinformatics to revolutionize the discovery of novel, natural and scientifically proven active ingredients that promote and manage our health.
The company’s disruptive computational approach to discovery uses artificial intelligence and DNA analysis to, for the first time ever, rapidly and efficiently provide access to the most health-benefiting components within food called peptides. Nuritas’s patented life-changing peptides provide unique solutions for the maintenance of health and wellness. These benefits include: anti-inflammatory activity, antimicrobial activity, muscle recovery enhancement, skin anti-aging solutions, and the potential management of blood sugar levels for type 2 diabetics. Put in a nutshell, the company discovers and unlocks ingredients from food sources in a completely unique way, providing natural, safe and sustainable health solutions.
In July 2015, the company received global recognition for the impact its technology will have on the future of food - Nuritas was awarded the Top Innovation award at the Forbes ‘Reinventing America Summit’.
We would love to hear about your investment opportunity.
To better appreciate the opportunity, we would like to know:
· the type of products or services you are developing,
· the industries and markets you intend to address,
· why you think your proposition is innovative and will have an impact on the foreseeable protein shortage.
We understand that the privacy of all information you provide is of primary importance and are committed to ensuring the ethical treatment and safeguarding of confidential information.
110 Amoy Street, Level 2
+(65) 6817 3765